Perora develops a polymer-based fat-binding medical device as a novel platform for weight management and the treatment of obesity.
HTGF invests in novel approach for the treatment of Obesity and Diabetes Type II – perora
perora GmbH, a new, privately held biotech company, that was incorporated in June 2013, announced today the closing of its seed venture capital financing round led by High-Tech-Gründerfonds. perora´s operations and headquarters are based in Heidelberg. The company´s management team consists of Dr. Dirk Vetter,…
Im Neuenheimer Feld 518
03. Jun 2013